
Tulisokibart was designed to help address immuno-fibrosis, a key driver of disease progression in HS

The acquisition will advance innovation for patients with rare skin diseases

The data underlines the consequences of disrupted sleep for patients and caregivers

The company’s R&D and commercial expertise represent valuable capabilities for future Chinese partners

TK2d is an extremely rare disease characterised by severe and progressive muscle weakness

The disease affects around 1% of the population in most studied countries

Topline results demonstrated treatment efficacy for both conditions

The study demonstrated a sustained reduction in seizures for patients

UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...

The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

The inflammatory skin condition affects over 26 million people in the US

We are deeply saddened by the recent passing of Dr. Robert Sidbury. Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, researchers, and...